Keyphrases
Blood Pressure Response
82%
Hydrochlorothiazide
80%
Hypertension
79%
Antihypertensive Response
55%
Antihypertensive Drugs
43%
Blood Pressure
41%
Diastolic Blood Pressure
35%
Atenolol
34%
Essential Hypertension
33%
Ambulatory Blood Pressure
32%
Hypertensive
31%
Plasma Renin Activity
27%
Thiazide Diuretics
27%
African American
25%
Antihypertensive Therapy
23%
Hypertension Management
21%
Aldosterone
19%
Pharmacogenomics
18%
White People
18%
Ambulatory Blood Pressure Monitoring
18%
Antihypertensive Drug Therapy
18%
Association Analysis
18%
Genomic Association
18%
Monotherapy
16%
High Blood Pressure
16%
Office Blood Pressure
15%
Albumin-to-creatinine Ratio
15%
Systolic Blood Pressure
15%
Chronic Kidney Disease
14%
Blood Pressure Level
14%
Inter-individual Variation
13%
Serum Creatinine
13%
European American
13%
Black Men
12%
People of Color
12%
Genetic Predictors
12%
Plasma Aldosterone Concentration
12%
Leukoaraiosis
12%
Primary Aldosteronism
12%
Genetic Epidemiology
11%
Initial Treatment
11%
Uncomplicated Hypertension
10%
Hypertensive Patients
10%
Large Artery Atherosclerosis
10%
Drug Response
10%
Angiotensin Receptor Blockers
10%
Drug Therapy
9%
Diuretics
9%
Transesophageal Echocardiography
9%
Confidence Interval
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antihypertensive Agent
100%
Hydrochlorothiazide
50%
Renin
47%
Disease
32%
Pharmacotherapy
30%
Hypertension
29%
Antihypertensive Therapy
28%
Essential Hypertension
27%
Atenolol
24%
Aortic Atherosclerosis
24%
Thiazide Diuretic Agent
21%
Atherosclerosis
20%
Monotherapy
17%
Pharmacogenetics
16%
Pharmacogenomics
15%
Artery Disease
13%
Candesartan
13%
Angiotensin Receptor Antagonist
12%
Cardiovascular Disease
11%
Nitrendipine
10%
Aldosterone
9%
Genetic Epidemiology
9%
Primary Hyperaldosteronism
9%
End Stage Renal Disease
9%
Hypotension
9%
Coronary Artery Disease
9%
Diuretic Agent
9%
Diabetes Mellitus
9%
Clinical Trial
8%
Cardiovascular Risk
8%
Angiotensin
7%
Creatinine
7%
Atrial Fibrillation
7%
Parathyroid Hormone
7%
Hyperglycemia
7%
Endothelial Nitric Oxide Synthase
6%
Calcium Channel Blocker
6%
Adducin
6%
C Reactive Protein
6%
Propranolol
6%
Hypokalemia
6%
Resistant Hypertension
6%
Add on Therapy
6%
Thoracic Aorta Aneurysm
6%
Cerebrovascular Disease
6%
Isotopes of Potassium
6%
Serine/Threonine Protein Kinase WNK1
6%
Epileptic Absence
6%
Hydrochlorothiazide Plus Valsartan
6%
Celiprolol
6%
Medicine and Dentistry
Blood Pressure
49%
Antihypertensive Agent
30%
Atherosclerosis
26%
Hypertension
25%
Hydrochlorothiazide
24%
Aortic Atherosclerosis
24%
Diastolic Blood Pressure
16%
Drug Therapy
16%
Population
15%
Primary Hyperaldosteronism
15%
Essential Hypertension
14%
Antihypertensive Therapy
14%
Disease
14%
Blood Pressure Monitoring
14%
Creatinine
13%
Artery Disease
12%
Transesophageal Echocardiography
12%
Atenolol
12%
Renin
12%
Aldosterone
12%
Apoplexy
11%
Thoracic Aorta
9%
Coronary Artery Disease
9%
Diagnostic Accuracy
9%
Sodium Intake
8%
Ambulatory Blood Pressure
8%
Pharmacogenomics
7%
Awareness
7%
Cerebral Atrophy
7%
Atrial Fibrillation
7%
Systolic Blood Pressure
7%
Thiazide Diuretic Agent
7%
Middle Age
7%
Hyperglycemia
7%
Child
7%
Pressure Control
6%
Genetic Epidemiology
6%
C Reactive Protein
6%
Hypokalemia
6%
Systolic Function
6%
Microalbuminuria
6%
Cerebrovascular Disease
6%
Angioplasty
6%
Short Course Therapy
6%
Serine/Threonine Protein Kinase WNK1
6%
Subgroup Analysis
6%
Health Outcomes
6%
Resistant Hypertension
6%
Marker Gene
6%
Side Effect
6%